Drugs that contain Empagliflozin

1. Drug name - JARDIANCE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7713938 BOEHRINGER INGELHEIM Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
Apr, 2027

(4 years from now)

US7579449 BOEHRINGER INGELHEIM Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
Aug, 2028

(5 years from now)

CN1930141A BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzol Derivatives, Drugs Containing Said Compounds, The Use Thereof And Method For The Production Thereof
May, 2014

(8 years ago)

CN103450129B BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzol Derivatives, Drugs Containing Said Compounds, The Use Thereof And Method For The Production Thereof
May, 2021

(1 year, 4 months ago)

CN103450129A BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzol Derivatives, Drugs Containing Said Compounds, The Use Thereof And Method For The Production Thereof
May, 2021

(1 year, 4 months ago)

CN103467423A BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzol Derivatives, Drugs Containing Said Compounds, The Use Thereof And Method For The Production Thereof
Sep, 2021

(1 year, 24 days ago)

CN103435581A BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzol Derivatives, Drugs Containing Said Compounds, The Use Thereof And Method For The Production Thereof
Sep, 2021

(1 year, 24 days ago)

CN103435581B BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Phenyl Derivatives, Medicaments Containing Said Compounds, Use Thereof, And Method For Manufacturing The Same
Sep, 2021

(1 year, 24 days ago)

CN103467423B BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzol Derivatives, Drugs Containing Said Compounds, The Use Thereof And Method For The Production Thereof
Sep, 2021

(1 year, 24 days ago)

CN101155794B BOEHRINGER INGELHEIM 1 - -4-[Beta] -D - Glucopyranose - -1) -2-[4 - ((S) - Tetrahydrofuran - -3 - Yloxy) - Benzyl] - Crystal Form Of Benzene, Preparation Method Thereof And Use For Preparing Medicine
May, 2026

(3 years from now)

CN101155794A BOEHRINGER INGELHEIM Crystalline Form Of 1-Chloro-4-(Betal-D-Glucopyranos-1-Radical)-2-[4-((S)-Tetrahydrofuran-3-Yloxy)-Benzyl]-Benzene, A Method For Its Preparation And The Use Thereof For Preparing Medicaments
May, 2026

(3 years from now)

IN200604844P1 BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzol Derivatives, Drugs Containing Said Compounds, The Use Thereof And Method For The Production Thereof
Mar, 2025

(2 years from now)

IN268846B BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzenol Derivative, Drug Containing Said Compound, The Use Thereof And Method For The Production Thereof
Mar, 2025

(2 years from now)

EP1828216B1 BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzene Derivatives, Medicaments Containing Such Compounds, Their Use And Process For Their Manufacture
Dec, 2025

(3 years from now)

EP1828216A2 BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzene Derivatives, Medicaments Containing Such Compounds, Their Use And Process For Their Manufacture
Dec, 2025

(3 years from now)

EP1888552A1 BOEHRINGER INGELHEIM Crystalline Form Of 1-Chloro-4-(ß-D-Glucopyranos-1-Yl)-2-[4-((S)-Tetrahydrofuran-3-Yloxy)-Benzyl]-Benzene, A Method For Its Preparation And The Use Thereof For Preparing Medicaments
May, 2026

(3 years from now)

EP1888552B1 BOEHRINGER INGELHEIM Crystalline Form Of 1-Chloro-4-(ß-D-Glucopyranos-1-Yl)-2-[4-((S)-Tetrahydrofuran-3-Yloxy)-Benzyl]-Benzene, A Method For Its Preparation And The Use Thereof For Preparing Medicaments
May, 2026

(3 years from now)

EP1730131A1 BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzol Derivatives, Drugs Containing Said Compounds, The Use Thereof And Method For The Production Thereof
May, 2029

(6 years from now)

EP1730131B1 BOEHRINGER INGELHEIM Glucopyranosyl-Substituted Benzol Derivatives, Drugs Containing Said Compounds, The Use Thereof And Method For The Production Thereof
May, 2029

(6 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8551957 BOEHRINGER INGELHEIM Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate Oct, 2029

(7 years from now)

US11090323 BOEHRINGER INGELHEIM Pharmaceutical composition, methods for treating and uses thereof Apr, 2034

(11 years from now)

US10258637 BOEHRINGER INGELHEIM Pharmaceutical composition, methods for treating and uses thereof Apr, 2034

(11 years from now)

US9949997 BOEHRINGER INGELHEIM Pharmaceutical composition, methods for treating and uses thereof May, 2034

(11 years from now)

US9949998 BOEHRINGER INGELHEIM Pharmaceutical composition, methods for treating and uses thereof Jun, 2034

(11 years from now)

Treatment: Method of treating type 2 diabetes mellitus by administering linagliptin in combination with empagliflozin; Method of treating type 2 diabetes mellitus in a patient with renal impairment (30 ml/min/1.73 m2<=egfr<60 ml/min/1.73 m2) by once daily administration of 10 mg or 25 mg of empagliflozin; Method of treating type 2 diabetes mellitus in a patient with renal impairment (45 ml/min/1.73 m2<=egfr<60 ml/min/1.73 m2) by once daily administration of 10 mg or 25 mg of empagliflozin; Method of reducing the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease by once daily administration of 10 mg or 25 mg of empagliflozin; method for reducing the risk of cardiovascular death plus hospitalization for heart failure in adults with type 2 diabetes mellitus, heart failure and reduced ejection fraction by once daily administration of empagliflozin

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
10MG TABLET;ORAL Prescription
25MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.